neuromental development dexamethasone neuromental development
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children born to mothers participating in the Phase 1 project who received dexamethasone at doses of 4, 5, and 6 mg. 2. Children living with their parents or guardians who regularly take care of the children can answer questions about child development. 3. Parents and guardians can bring their children to receive developmental examinations at the National Institute for Child and Family Development, Salaya, Mahidol University, Nakhon Pathom. 4. Parents or guardians who have signed their consent to participate in the research.
Exclusion criteria
Exclusion criteria: 1. Children with disabilities such as blindness, color blindness, deafness that cannot be examined 2. Children diagnosed with developmental disabilities such as autism (ASD) 3. Children who do not understand Thai or Thai instructions and cannot speak Thai 4. Parents or guardians do not understand Thai 5. Parents or guardians do not sign their consent to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| neuromental development 3 years normal abnormal | — |
Secondary
| Measure | Time frame |
|---|---|
| neuromental development in 4, 5 and 6 mg group 3 years normal abnormal | — |
Countries
Thailand
Contacts
Mahidol university